Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges

S Dutta, S Hornung, HB Taha, G Bitan - Acta neuropathologica, 2023 - Springer
Extracellular vesicles (EVs), including exosomes, microvesicles, and oncosomes, are nano-
sized particles enclosed by a lipid bilayer. EVs are released by virtually all eukaryotic cells …

Translational molecular imaging and drug development in Parkinson's disease

A Haider, NH Elghazawy, A Dawoud… - Molecular …, 2023 - Springer
Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects
elderly people and constitutes a major source of disability worldwide. Notably, the …

An update on pathogenesis and clinical scenario for Parkinson's disease: diagnosis and treatment

H Adam, SCB Gopinath, MK Md Arshad, T Adam… - 3 Biotech, 2023 - Springer
In severe cases, Parkinson's disease causes uncontrolled movements known as motor
symptoms such as dystonia, rigidity, bradykinesia, and tremors. Parkinson's disease also …

Dopamine transporter (DAT) imaging in Parkinson's disease and related disorders

T Brücke, C Brücke - Journal of Neural Transmission, 2022 - Springer
This review gives an insight into the beginnings of dopamine transporter (DAT) imaging in
the early 1990s, focussing on single photon emission tomography (SPECT). The …

Molecular Imaging in Parkinsonian Disorders—What's New and Hot?

S Prange, H Theis, M Banwinkler, T van Eimeren - Brain Sciences, 2022 - mdpi.com
Highlights Imaging of the dopamine transporter (DAT)(in particular using 11C-or 18F-PE2I)
most reliably and precisely measures neurodegeneration of the dopaminergic system in …

Plasma α‐synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson's disease

J Ren, C Pan, Y Wang, C Xue, H Lin… - Journal of …, 2022 - Wiley Online Library
The use of a diagnostic panel comprising multiple biomarkers has the potential to accurately
diagnose Parkinson's disease (PD). However, a panel consisting solely of plasma …

Recent advances in imaging agents anchored with pH (Low) insertion peptides for cancer theranostics

YC Liu, ZX Wang, JY Pan, LQ Wang, XY Dai, KF Wu… - Molecules, 2023 - mdpi.com
The acidic extracellular microenvironment has become an effective target for diagnosing
and treating tumors. A pH (low) insertion peptide (pHLIP) is a kind of peptide that can …

SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F] FDG PET Imaging, Version 2.0

J Arbizu, S Morbelli, S Minoshima… - Journal of Nuclear …, 2024 - jnm.snmjournals.org
PREAMBLE The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an
international scientific and professional organization founded in 1954 to promote the …

Differences in Striatal Metabolism in [18F]FDG PET in Parkinson's Disease and Atypical Parkinsonism

AP Seiffert, A Gómez-Grande, L Alonso-Gómez… - Diagnostics, 2022 - mdpi.com
Neurodegenerative parkinsonisms affect mainly cognitive and motor functions and are
syndromes of overlapping symptoms and clinical manifestations such as tremor, rigidness …

Nanoscale contrast agents: A promising tool for ultrasound imaging and therapy

J Wang, Y Wang, L Zhong, F Yan, H Zheng - Advanced Drug Delivery …, 2024 - Elsevier
Nanoscale contrast agents have emerged as a versatile platform in the field of biomedical
research, offering great potential for ultrasound imaging and therapy. Various kinds of …